NAC Clinical analysis

NAC Benefits for Women: PCOS, Fertility and Pregnancy Evidence

NAC benefits for women reviewed: PCOS, ovulation, endometrial thickness, insulin sensitivity, fertility and pregnancy—plus what hormone and menopause claims do not prove.

Published
Last reviewed
Reading time
13 min
Sources cited
5
On this page

The strongest women-specific NAC evidence is in polycystic ovary syndrome (PCOS), not generic “female hormone balance.” Trials and meta-analyses have examined ovulation, endometrial thickness, progesterone, insulin sensitivity and fertility-related outcomes. Pregnancy is a separate evidence category with medical and investigational uses.

NAC benefits for women at a glance

Claim Evidence
PCOS reproductive outcomes Promising pooled evidence.
Insulin sensitivity in PCOS Some positive clinical evidence.
Female fertility outside PCOS Not broadly established.
Pregnancy supplementation Condition-specific research; not routine prenatal use.
Menopause / “hormone balance” Insufficient evidence.

NAC for PCOS

PCOS is where the female-specific evidence is deepest.

A 2025 systematic review and meta-analysis included 22 studies and 2,515 participants. NAC was associated with improvements in progesterone and endometrial thickness, while several other hormone outcomes—including estradiol, SHBG and FSH—were not significantly different.

The analysis included heterogeneous comparators such as placebo, metformin and clomiphene, and some authors had commercial employment relevant to wellness services. That does not erase the findings, but it lowers confidence in broad claims.

Ovulation, pregnancy and live-birth signals

An earlier meta-analysis of eight randomized PCOS trials found favorable pooled signals versus placebo for ovulation, pregnancy and live birth, but NAC was not consistently superior to metformin.

The underlying trials were relatively small and heterogeneous, so these outcomes should be described as promising rather than guaranteed fertility benefits.

Insulin sensitivity

A small clinical study found that NAC improved peripheral insulin sensitivity and reduced insulin exposure and androgen indices mainly in hyperinsulinemic women with PCOS.

The study was limited by a very small placebo subgroup and nonuniform dosing, so it is mechanistically useful rather than definitive.

Does NAC “balance hormones”?

That phrase is too vague to be useful.

PCOS research measures specific hormones and metabolic endpoints. Some improve; others do not. There is no evidence that NAC universally normalizes estrogen, progesterone, testosterone, thyroid hormones and stress hormones in healthy women.

NAC and female fertility outside PCOS

Most favorable reproductive evidence is tied to PCOS or specific infertility protocols. Different causes of infertility—tubal disease, diminished ovarian reserve, endometriosis, male-factor infertility and age-related decline—cannot be treated as one condition.

NAC should therefore not be marketed as a general fertility supplement for every woman trying to conceive.

NAC during pregnancy

Pregnancy requires separate analysis. NAC is used medically when acetaminophen poisoning requires treatment and has been studied in specialized antenatal protocols.

A 2026 randomized pilot in impending preterm birth failed its primary cord-blood glutathione endpoint but reported encouraging secondary signals. A separate 2026 systematic review found promising but heterogeneous neonatal findings in chorioamnionitis/Triple I research.

Neither supports routine prenatal NAC for every pregnancy. See NAC in pregnancy.

What about menopause?

There is not a strong clinical evidence base showing NAC meaningfully treats hot flashes, menopausal symptoms, bone loss or the broader endocrine transition of menopause.

Claims that NAC is a “hormone-balancing” menopause supplement are ahead of the evidence.

Skin, hair and beauty claims

NAC's glutathione biology makes beauty claims mechanistically tempting, but direct oral evidence for wrinkles, skin hydration, pigmentation or hair growth is weak.

See NAC skin benefits for the dermatology evidence and NAC for trichotillomania for the very different hair-pulling evidence.

Bottom line

For women, NAC is most interesting in PCOS. The reproductive and metabolic signals are meaningful enough to deserve careful attention, but they do not justify turning NAC into a universal female-hormone, fertility or pregnancy supplement. The evidence is strongest when the exact condition is named.

Frequently asked questions

What are the main NAC benefits for women?

The most developed women-specific evidence is in PCOS, with studies examining ovulation, endometrial thickness, progesterone, insulin sensitivity and fertility-related outcomes.

Does NAC help PCOS?

Meta-analyses show favorable signals for selected reproductive and metabolic outcomes, but the studies are heterogeneous and NAC is not uniformly superior to standard treatments.

Can NAC improve female fertility?

Some PCOS trials report improved ovulation, pregnancy or related reproductive outcomes. That evidence should not be generalized to every cause of infertility.

Does NAC balance female hormones?

That phrase is too broad. PCOS studies report changes in selected hormones and metabolic measures, but NAC has not been proven to 'balance hormones' in healthy women.

Can women take NAC during pregnancy?

NAC has specific medical and investigational pregnancy uses, but routine prenatal supplementation is not established. See the pregnancy-specific evidence review.

Does NAC help menopause?

There is not a strong human evidence base establishing NAC as a menopause treatment or a general hormone-replacement alternative.

Share this article

Send the research to someone who would find it useful.

Facebook X LinkedIn Reddit WhatsApp Email

Sources & article history

Sources (5)
  1. Isabel Viña, et al. Efficacy of N-Acetylcysteine in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis Nutrients. 2025;17(2):284.
  2. Divyesh Thakker, et al. N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials Obstet Gynecol Int. 2015;2015:817849.
  3. Anna Maria Fulghesu, et al. N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome Fertil Steril. 2002;77(6):1128-1135.
  4. Alice Küster, et al. Antenatal N-acetylcysteine supplementation in pregnant women with impending preterm birth: a prospective randomized placebo-controlled trial Pediatr Res. 2026;Online ahead of print.
  5. Fawzia Mohamed Elgharbawy, et al. Fetal and neonatal effects of N-acetylcysteine for maternal chorioamnionitis: a systematic review Front Pediatr. 2026;14:1819220.
Article history (1)
  1. Published with PCOS, fertility and pregnancy evidence separated from broad female-hormone and wellness claims.